EpiFix® Study Shows 92.5% Healing Rate Over 12 Weeks, with Healing Faster with Weekly vs Bi-Weekly Application

A newly published, prospective, randomised, comparative study suggests that diabetic foot ulcers are mostly healed with the application of MiMedx’s EpiFix allograft. And it seems weekly application speeds things up compared with bi-weekly.